Published in N Engl J Med on May 19, 1983
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol (1983) 3.36
Rethinking gender, heterosexual men, and women's vulnerability to HIV/AIDS. Am J Public Health (2010) 2.66
AIDS and haemophilia: morbidity and morality in a well defined population. Br Med J (Clin Res Ed) (1985) 2.54
Use of oral contraceptives by adolescents and its consequences in Finland 1981-91. BMJ (1992) 2.23
The history of the condom. J R Soc Med (1993) 1.83
The acquired immune deficiency syndrome. Clin Exp Immunol (1984) 1.62
Antiretrovirals and safer conception for HIV-serodiscordant couples. Curr Opin HIV AIDS (2012) 1.51
Intravenous drug users and the acquired immune deficiency syndrome. Public Health Rep (1984) 1.18
AIDS: the African connection. Br Med J (Clin Res Ed) (1985) 1.11
Heterosexual transmission of human immunodeficiency virus. Br Med J (Clin Res Ed) (1988) 1.07
The innate immune system: gatekeeper to the female reproductive tract. Immunology (2004) 1.01
Seroprevalence, risk factors and attitude to HIV-1 in a representative sample of lesbians in Turin. Genitourin Med (1994) 1.00
The retinal lesions of the acquired immune deficiency syndrome. Trans Am Ophthalmol Soc (1984) 0.97
Heterosexual transmission of human immunodeficiency virus (HIV) in the United States. Bull N Y Acad Med (1989) 0.96
Gastrointestinal histoplasmosis in suspected acquired immunodeficiency syndrome. West J Med (1985) 0.89
AIDS in Haitian immigrants and in a Caucasian woman closely associated with Haitians. Can Med Assoc J (1983) 0.85
HIV transmission to female sexual partners of HIV antibody-positive hemophiliacs. Public Health Rep (1988) 0.79
HIV and women: when words speak louder than actions. Am J Public Health (2004) 0.78
Thirty years of the human immunodeficiency virus epidemic and beyond. Int J Oral Sci (2013) 0.77
Proposed immunopathogenic factors associated with progression from human immunodeficiency virus seropositivity to clinical disease. J Clin Microbiol (1987) 0.77
Acquired immunodeficiency syndrome: more than a health-related dilemma. Clin Microbiol Rev (1989) 0.76
Heterosexual transmission of human immunodeficiency virus infection - Strategies for prevention. Can J Infect Dis (1991) 0.75
Unreviewed reports. Br Med J (Clin Res Ed) (1985) 0.75
AIDS and hepatitis B cannot be venereal diseases. Can Med Assoc J (1984) 0.75
Heterosexual transmission of the human immunodeficiency virus: a seroepidemiological study. Arch Dermatol Res (1989) 0.75
Opportunistic infections and impaired cell-mediated immune responses in patients with the acquired immune deficiency syndrome. Trans Am Clin Climatol Assoc (1984) 0.75
Pathology-important advances in clinical medicine: secondary diseases in immunosuppressed patients. West J Med (1984) 0.75
Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU). Yale J Biol Med (1988) 0.75
Pathology-important advances in clinical medicine: cytomegalovirus infections in infants. West J Med (1984) 0.75
AIDS and the obstetrician-gynecologist. J Natl Med Assoc (1987) 0.75
AIDS and the accident and emergency department. Arch Emerg Med (1985) 0.75
Pathology-important advances in clinical medicine: the role of coronary collateral arteries in myocardial ischemia. West J Med (1984) 0.75
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med (1982) 4.98
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
The will and the ways: development and validation of an individual-differences measure of hope. J Pers Soc Psychol (1991) 4.55
Transmission of the human immunodeficiency virus. N Engl J Med (1987) 4.17
Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci (1968) 4.00
Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 3.86
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol (1997) 3.66
Suicide within 12 months of contact with mental health services: national clinical survey. BMJ (1999) 3.61
Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med (1982) 3.29
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci (1967) 3.17
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. Malar J (2006) 2.65
Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science (1976) 2.34
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA (1983) 2.29
Survival differences in patients with AIDS. J Acquir Immune Defic Syndr (1991) 2.23
A procedure for culture of cells from mouse tail biopsies: brief communication. J Natl Cancer Inst (1978) 2.22
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood (2000) 2.08
Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06
Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis (2012) 2.03
Lincomycin: activity in vitro and absorption and excretion in normal young men. Am J Med Sci (1967) 2.00
Genetic transcription and translation specifying chloroplast components in Chlamydomonas reinhardi. Biochemistry (1971) 2.00
Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob Agents Chemother (1978) 1.96
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
The natural history of Niemann-Pick disease type C in the UK. J Inherit Metab Dis (2006) 1.87
Risk-adjusted analysis of surgeon performance: a 1-year study. Br J Surg (1995) 1.81
Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis (2001) 1.77
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Is prevaccination screening for hepatitis B among sexually active adolescents cost-effective? Clin Infect Dis (1998) 1.74
Absorption and excretion of five tetracycline analogues in normal young men. Am J Med Sci (1968) 1.72
Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob Agents Chemother (1980) 1.72
Mental disorder and clinical care in people convicted of homicide: national clinical survey. BMJ (1999) 1.71
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
p53 mutation is associated with progression in follicular lymphomas. Blood (1993) 1.69
Structures of benzo(a)pyrene--nucleic acid adducts formed in human and bovine bronchial explants. Nature (1977) 1.68
Outcome data from the LEAP (Live, Eat and Play) trial: a randomized controlled trial of a primary care intervention for childhood overweight/mild obesity. Int J Obes (Lond) (2006) 1.66
Patterns of second malignant neoplasms in children. Cancer (1977) 1.65
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
Clinical evaluation of cephaloridine. Arch Intern Med (1968) 1.59
Septicemia in patients on chronic hemodialysis. Ann Intern Med (1978) 1.59
The era of adherence to HIV therapy. Ann Intern Med (1998) 1.55
Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med (1996) 1.54
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood (1997) 1.52
Abdominal compartment syndrome in patients with isolated extraperitoneal injuries. J Trauma (2000) 1.52
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol (2001) 1.51
Kaposi's sarcoma in homosexual men. A seroepidemiologic case-control study. Ann Intern Med (1984) 1.50
The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am J Epidemiol (1969) 1.48
Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1966) 1.48
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol (1987) 1.47
A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. Gastroenterology (1997) 1.46
Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS. J Infect Dis (1988) 1.45
Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome. Lancet (1983) 1.45
Topical nitroglycerin: a potential treatment for impotence. J Urol (1989) 1.44
Criteria for the diagnosis of infective endocarditis. Clin Infect Dis (1994) 1.44
Tuberculosis infection control in rural South Africa: survey of knowledge, attitude and practice in hospital staff. J Hosp Infect (2011) 1.44
Low occupational risk of human immunodeficiency virus infection among dental professionals. N Engl J Med (1988) 1.43
Mucociliary clearance abnormalities in the HIV-infected patient: a precursor to acute sinusitis. Laryngoscope (1995) 1.42
Computed tomography of the head before a lumbar puncture in suspected meningitis -- is it helpful? N Engl J Med (2001) 1.41
Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1992) 1.40
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
Severity of articular cartilage abnormality in patients with osteoarthritis: evaluation with fast spin-echo MR vs arthroscopy. AJR Am J Roentgenol (1994) 1.39
Laparoscopic cholecystectomy in surgical training. BMJ (1994) 1.39
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol (1991) 1.39
The evaluation of patients with human immunodeficiency virus-related disorders and brain mass lesions. Arch Intern Med (1991) 1.38
Junior doctors, nurses, and drips. BMJ (1991) 1.38
Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). Ann Intern Med (1988) 1.37
Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis (2012) 1.37